These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

449 related items for PubMed ID: 1693165

  • 1. Characterization and immunological properties of influenza A virus nucleoprotein (NP): cell-associated NP isolated from infected cells or viral NP expressed by vaccinia recombinant virus do not confer protection.
    Stitz L, Schmitz C, Binder D, Zinkernagel R, Paoletti E, Becht H.
    J Gen Virol; 1990 May; 71 ( Pt 5)():1169-79. PubMed ID: 1693165
    [Abstract] [Full Text] [Related]

  • 2. Searching for MHC-restricted anti-viral antibodies: antibodies recognizing the nucleoprotein of influenza virus dominate the serological response of C57BL/6 mice to syngeneic influenza-infected cells.
    Tamminen WL, Wraith D, Barber BH.
    Eur J Immunol; 1987 Jul; 17(7):999-1006. PubMed ID: 3497045
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Primary pulmonary cytotoxic T lymphocytes induced by immunization with a vaccinia virus recombinant expressing influenza A virus nucleoprotein peptide do not protect mice against challenge.
    Lawson CM, Bennink JR, Restifo NP, Yewdell JW, Murphy BR.
    J Virol; 1994 Jun; 68(6):3505-11. PubMed ID: 7514677
    [Abstract] [Full Text] [Related]

  • 5. Development and application of monoclonal antibodies against avian influenza virus nucleoprotein.
    Yang M, Berhane Y, Salo T, Li M, Hole K, Clavijo A.
    J Virol Methods; 2008 Feb; 147(2):265-74. PubMed ID: 18006085
    [Abstract] [Full Text] [Related]

  • 6. Dose dependence of CTL precursor frequency induced by a DNA vaccine and correlation with protective immunity against influenza virus challenge.
    Fu TM, Guan L, Friedman A, Schofield TL, Ulmer JB, Liu MA, Donnelly JJ.
    J Immunol; 1999 Apr 01; 162(7):4163-70. PubMed ID: 10201942
    [Abstract] [Full Text] [Related]

  • 7. The roles of influenza virus haemagglutinin and nucleoprotein in protection: analysis using vaccinia virus recombinants.
    Andrew ME, Coupar BE, Boyle DB, Ada GL.
    Scand J Immunol; 1987 Jan 01; 25(1):21-8. PubMed ID: 3492756
    [Abstract] [Full Text] [Related]

  • 8. Anti-viral protection and prevention of lymphocytic choriomeningitis or of the local footpad swelling reaction in mice by immunization with vaccinia-recombinant virus expressing LCMV-WE nucleoprotein or glycoprotein.
    Hany M, Oehen S, Schulz M, Hengartner H, Mackett M, Bishop DH, Overton H, Zinkernagel RM.
    Eur J Immunol; 1989 Mar 01; 19(3):417-24. PubMed ID: 2468501
    [Abstract] [Full Text] [Related]

  • 9. Homotypic and heterotypic protection against influenza virus infection in mice by recombinant vaccinia virus expressing the haemagglutinin or nucleoprotein of influenza virus.
    Endo A, Itamura S, Iinuma H, Funahashi S, Shida H, Koide F, Nerome K, Oya A.
    J Gen Virol; 1991 Mar 01; 72 ( Pt 3)():699-703. PubMed ID: 2005435
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Increased Protein Degradation Improves Influenza Virus Nucleoprotein-Specific CD8+ T Cell Activation In Vitro but Not in C57BL/6 Mice.
    Altenburg AF, van de Sandt CE, van Trierum SE, De Gruyter HLM, van Run PRWA, Fouchier RAM, Roose K, Saelens X, Volz A, Sutter G, de Vries RD, Rimmelzwaan GF.
    J Virol; 2016 Nov 15; 90(22):10209-10219. PubMed ID: 27581985
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The influence of the isolation technique of influenza virus nucleoprotein on its antigenic properties.
    Khristova ML, Egorenkova EM, Zagidullin NV, Sokolova MV, Busse TL, Leonov SV, Kharitonenkov IG.
    Acta Virol; 1987 Aug 15; 31(4):289-97. PubMed ID: 2892378
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. No recognition of MHC class II+ cells infected with a vaccinia virus encoding influenza type A nucleoprotein by class II-restricted T cells.
    Freer G, Senesi S.
    Immunol Lett; 1993 Jun 15; 36(3):305-12. PubMed ID: 8370602
    [Abstract] [Full Text] [Related]

  • 19. Immunization with plasmid DNA encoding influenza A virus nucleoprotein fused to a tissue plasminogen activator signal sequence elicits strong immune responses and protection against H5N1 challenge in mice.
    Luo M, Tao P, Li J, Zhou S, Guo D, Pan Z.
    J Virol Methods; 2008 Dec 15; 154(1-2):121-7. PubMed ID: 18789973
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.